Investors

News Releases

Reprints Desk Designated as a Reprints Channel Distributor for Elsevier Healthcare Content
Healthcare Marketers and Medical Affairs Professionals to Benefit from Additional Source for Elsevier Reprint Orders

Los Angeles, CA (PRWEB) December 17, 2008 -- Reprints Desk, Inc., the content workflow company (http://www.reprintsdesk.com), today announced that Elsevier is expanding its existing relationship with Reprints Desk to include the ability to sell and deliver Elsevier reprints. The agreement further enhances the service speed and ordering options for Reprints Desk clients in healthcare who procure scientific articles in bulk for use in sales and marketing, and supports Elsevier's ongoing commitment to ensure continued growth in key sales channels.

 

 

 

The agreement between Reprints Desk and Elsevier is effective immediately and enables Reprints Desk to manage orders received from its growing base of clients in pharmaceuticals, biotechnology, medical devices, and healthcare communications. Reprints Desk will leverage the agreement to deliver Elsevier content more quickly and efficiently, and integrate its new capabilities with previously acquired scientific, technical, and medical (STM) printer Pools Press (http://www.poolspress.com).

 

Elsevier, the world's leading publisher of STM information products and services, will be expanding its market penetration through its relationship with Reprints Desk. "We want to work with inventive, customer-oriented reprint channel partners who extend Elsevier's ability to serve the healthcare market," said Luis Portero, Elsevier's Vice President of Commercial Sales, U.S. Journals.

 

"This agreement between Elsevier and Reprints Desk demonstrates our shared emphasis on partnering in ways that will be most beneficial to customers," said Jan Peterson, Head of Publisher Relations at Reprints Desk. "It also builds upon our previous agreement in which Reprints Desk became the first commercial document delivery provider to secure rights for delivering Elsevier Science Direct articles (http://www.reprintsdesk.com/main/docdel_overview.aspx), opening the door wider for future collaborations."

 

 

About Reprints Desk®
Reprints Desk, Inc. (www.reprintsdesk.com), is a content technology and services company that simplifies how healthcare companies and other enterprises procure, manage and share scientific journal articles and other copyright-protected content. The company's workflow solutions and end user tools help customers to use peer-reviewed literature for product promotions, support research and regulatory submissions with document delivery, and improve content spend management. A partner to more than 100 scientific, technical, and medical (STM) publishers, Reprints Desk currently serves more than half of the world's Top-50 pharmaceutical companies and earned the #1 ranking in the 2008 Document Delivery Vendor Scorecard by Outsell, Inc. Reprints Desk is a Derycz Scientific, Inc., (OTC: DYSC.PK) company. For more information about Reprints Desk, contact Ian Palmer at (707) 658-1931.

 

About Elsevier
Elsevier is a world-leading publisher of scientific, technical and medical information products and services. Working in partnership with the global science and health communities, Elsevier's 7,000 employees in over 70 offices worldwide publish more than 2,000 journals and 1,900 new books per year, in addition to offering a suite of innovative electronic products, such as ScienceDirect, MD Consult, Scopus, bibliographic databases, and online reference works.

 

Elsevier is a global business headquartered in Amsterdam, The Netherlands and has offices worldwide. Elsevier is part of Reed Elsevier Group plc, a world-leading publisher and information provider. Operating in the science and medical, legal, education and business-to-business sectors, Reed Elsevier provides high-quality and flexible information solutions to users, with increasing emphasis on the Internet as a means of delivery. Reed Elsevier's ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).